It is time to stop using epirubicin to treat any patient with gastroesophageal adenocarcinoma Journal Article


Authors: Elimova, E.; Janjigian, Y. Y.; Mulcahy, M.; Catenacci, D. V.; Blum, M. A.; Almhanna, K.; Hecht, J. R.; Ajani, J. A.
Article Title: It is time to stop using epirubicin to treat any patient with gastroesophageal adenocarcinoma
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 4
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-02-01
Start Page: 475
End Page: 476
Language: English
ACCESSION: 121017574
DOI: 10.1200/jco.2016.69.7276
PROVIDER: EBSCOhost
PUBMED: 28129519
PROVIDER: cin20
DOI/URL:
Notes: Accession Number: 121017574 -- Entry Date: In Process -- Revision Date: 20170201 -- Publication Type: journal article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333 -- Source: cin20
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yelena Yuriy Janjigian
    394 Janjigian